Improving quality of life after breast cancer: dealing with symptoms.
Identifieur interne : 004753 ( Ncbi/Merge ); précédent : 004752; suivant : 004754Improving quality of life after breast cancer: dealing with symptoms.
Auteurs : Ana Catarina Pinto [Portugal] ; Evandro De AzambujaSource :
- Maturitas [ 1873-4111 ] ; 2011.
Descripteurs français
- KwdFr :
- Antinéoplasiques (effets indésirables), Bouffées de chaleur (), Bouffées de chaleur (étiologie), Dépression (), Dépression (épidémiologie), Dépression (étiologie), Fatigue (), Fatigue (étiologie), Femelle, Humains, Infertilité féminine (), Infertilité féminine (étiologie), Lymphoedème (), Lymphoedème (épidémiologie), Qualité de vie, Survivants, Troubles de l'endormissement et du maintien du sommeil (), Troubles de l'endormissement et du maintien du sommeil (étiologie), Troubles de la cognition (), Troubles de la cognition (épidémiologie), Troubles de la cognition (étiologie), Tumeurs du sein (), Tumeurs du sein (psychologie).
- MESH :
- effets indésirables : Antinéoplasiques.
- psychologie : Tumeurs du sein.
- épidémiologie : Dépression, Lymphoedème, Troubles de la cognition.
- étiologie : Bouffées de chaleur, Dépression, Fatigue, Infertilité féminine, Troubles de l'endormissement et du maintien du sommeil, Troubles de la cognition.
- Bouffées de chaleur, Dépression, Fatigue, Femelle, Humains, Infertilité féminine, Lymphoedème, Qualité de vie, Survivants, Troubles de l'endormissement et du maintien du sommeil, Troubles de la cognition, Tumeurs du sein.
English descriptors
- KwdEn :
- Antineoplastic Agents (adverse effects), Breast Neoplasms (complications), Breast Neoplasms (psychology), Breast Neoplasms (therapy), Cognition Disorders (epidemiology), Cognition Disorders (etiology), Cognition Disorders (therapy), Depression (epidemiology), Depression (etiology), Depression (therapy), Fatigue (etiology), Fatigue (therapy), Female, Hot Flashes (etiology), Hot Flashes (therapy), Humans, Infertility, Female (etiology), Infertility, Female (therapy), Lymphedema (epidemiology), Lymphedema (therapy), Quality of Life, Sleep Initiation and Maintenance Disorders (etiology), Sleep Initiation and Maintenance Disorders (therapy), Survivors.
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- complications : Breast Neoplasms.
- epidemiology : Cognition Disorders, Depression, Lymphedema.
- etiology : Cognition Disorders, Depression, Fatigue, Hot Flashes, Infertility, Female, Sleep Initiation and Maintenance Disorders.
- psychology : Breast Neoplasms.
- therapy : Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Hot Flashes, Infertility, Female, Lymphedema, Sleep Initiation and Maintenance Disorders.
- Female, Humans, Quality of Life, Survivors.
Abstract
Advances in breast cancer therapies have given rise to a growing number of patient survivors. Nevertheless, these women deal with long-term sequelae that impair their quality of life and that are lacking satisfactory assessment and expeditious management. Importantly, a new era is raising in the oncology field, namely, survivorship.
DOI: 10.1016/j.maturitas.2011.09.008
PubMed: 22014722
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002421
- to stream PubMed, to step Curation: 002421
- to stream PubMed, to step Checkpoint: 002421
Links to Exploration step
pubmed:22014722Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Improving quality of life after breast cancer: dealing with symptoms.</title><author><name sortKey="Pinto, Ana Catarina" sort="Pinto, Ana Catarina" uniqKey="Pinto A" first="Ana Catarina" last="Pinto">Ana Catarina Pinto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Portuguese Institute of Oncology Francisco Gentil, EPE-Coimbra, Coimbra, Portugal. acatarinapinto@gmail.com</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Department of Medical Oncology, Portuguese Institute of Oncology Francisco Gentil, EPE-Coimbra, Coimbra</wicri:regionArea><wicri:noRegion>Coimbra</wicri:noRegion></affiliation></author><author><name sortKey="De Azambuja, Evandro" sort="De Azambuja, Evandro" uniqKey="De Azambuja E" first="Evandro" last="De Azambuja">Evandro De Azambuja</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:22014722</idno><idno type="pmid">22014722</idno><idno type="doi">10.1016/j.maturitas.2011.09.008</idno><idno type="wicri:Area/PubMed/Corpus">002421</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002421</idno><idno type="wicri:Area/PubMed/Curation">002421</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002421</idno><idno type="wicri:Area/PubMed/Checkpoint">002421</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002421</idno><idno type="wicri:Area/Ncbi/Merge">004753</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Improving quality of life after breast cancer: dealing with symptoms.</title><author><name sortKey="Pinto, Ana Catarina" sort="Pinto, Ana Catarina" uniqKey="Pinto A" first="Ana Catarina" last="Pinto">Ana Catarina Pinto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Portuguese Institute of Oncology Francisco Gentil, EPE-Coimbra, Coimbra, Portugal. acatarinapinto@gmail.com</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Department of Medical Oncology, Portuguese Institute of Oncology Francisco Gentil, EPE-Coimbra, Coimbra</wicri:regionArea><wicri:noRegion>Coimbra</wicri:noRegion></affiliation></author><author><name sortKey="De Azambuja, Evandro" sort="De Azambuja, Evandro" uniqKey="De Azambuja E" first="Evandro" last="De Azambuja">Evandro De Azambuja</name></author></analytic><series><title level="j">Maturitas</title><idno type="eISSN">1873-4111</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (adverse effects)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (psychology)</term><term>Breast Neoplasms (therapy)</term><term>Cognition Disorders (epidemiology)</term><term>Cognition Disorders (etiology)</term><term>Cognition Disorders (therapy)</term><term>Depression (epidemiology)</term><term>Depression (etiology)</term><term>Depression (therapy)</term><term>Fatigue (etiology)</term><term>Fatigue (therapy)</term><term>Female</term><term>Hot Flashes (etiology)</term><term>Hot Flashes (therapy)</term><term>Humans</term><term>Infertility, Female (etiology)</term><term>Infertility, Female (therapy)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (therapy)</term><term>Quality of Life</term><term>Sleep Initiation and Maintenance Disorders (etiology)</term><term>Sleep Initiation and Maintenance Disorders (therapy)</term><term>Survivors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques (effets indésirables)</term><term>Bouffées de chaleur ()</term><term>Bouffées de chaleur (étiologie)</term><term>Dépression ()</term><term>Dépression (épidémiologie)</term><term>Dépression (étiologie)</term><term>Fatigue ()</term><term>Fatigue (étiologie)</term><term>Femelle</term><term>Humains</term><term>Infertilité féminine ()</term><term>Infertilité féminine (étiologie)</term><term>Lymphoedème ()</term><term>Lymphoedème (épidémiologie)</term><term>Qualité de vie</term><term>Survivants</term><term>Troubles de l'endormissement et du maintien du sommeil ()</term><term>Troubles de l'endormissement et du maintien du sommeil (étiologie)</term><term>Troubles de la cognition ()</term><term>Troubles de la cognition (épidémiologie)</term><term>Troubles de la cognition (étiologie)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (psychologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term><term>Depression</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term><term>Depression</term><term>Fatigue</term><term>Hot Flashes</term><term>Infertility, Female</term><term>Sleep Initiation and Maintenance Disorders</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Cognition Disorders</term><term>Depression</term><term>Fatigue</term><term>Hot Flashes</term><term>Infertility, Female</term><term>Lymphedema</term><term>Sleep Initiation and Maintenance Disorders</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Dépression</term><term>Lymphoedème</term><term>Troubles de la cognition</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Bouffées de chaleur</term><term>Dépression</term><term>Fatigue</term><term>Infertilité féminine</term><term>Troubles de l'endormissement et du maintien du sommeil</term><term>Troubles de la cognition</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Quality of Life</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Bouffées de chaleur</term><term>Dépression</term><term>Fatigue</term><term>Femelle</term><term>Humains</term><term>Infertilité féminine</term><term>Lymphoedème</term><term>Qualité de vie</term><term>Survivants</term><term>Troubles de l'endormissement et du maintien du sommeil</term><term>Troubles de la cognition</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Advances in breast cancer therapies have given rise to a growing number of patient survivors. Nevertheless, these women deal with long-term sequelae that impair their quality of life and that are lacking satisfactory assessment and expeditious management. Importantly, a new era is raising in the oncology field, namely, survivorship.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22014722</PMID><DateCreated><Year>2011</Year><Month>11</Month><Day>07</Day></DateCreated><DateCompleted><Year>2012</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2011</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4111</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>4</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Maturitas</Title><ISOAbbreviation>Maturitas</ISOAbbreviation></Journal><ArticleTitle>Improving quality of life after breast cancer: dealing with symptoms.</ArticleTitle><Pagination><MedlinePgn>343-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.maturitas.2011.09.008</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Advances in breast cancer therapies have given rise to a growing number of patient survivors. Nevertheless, these women deal with long-term sequelae that impair their quality of life and that are lacking satisfactory assessment and expeditious management. Importantly, a new era is raising in the oncology field, namely, survivorship.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A search for English-language articles on Medline was undertaken covering the last 15 years, using the terms "cancer survivorship", "quality of life", "fatigue", "insomnia", "sleep disturbances", "depression", "cognitive dysfunction", "chemofog", "peripheral neuropathy", "fertility", "sexual behaviour", "menopause", "lymphedema", "physical activity" and "breast neoplasms". Selection was limited to systematic reviews and meta-analysis, but their reference list was examined to include papers of potential interest.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found the most common symptoms affecting breast cancer survivors were fatigue, insomnia, depression, cognitive dysfunction, reproductive and menopausal symptoms and lymphoedema.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Some of these symptoms have even been the objective of randomised controlled trials, but consistent data are missing. The available interventions include pharmacological, behavioural therapies and complementary and alternative medicine approaches and will mostly depend on the type of symptom.</AbstractText><CopyrightInformation>Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Ana Catarina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Portuguese Institute of Oncology Francisco Gentil, EPE-Coimbra, Coimbra, Portugal. acatarinapinto@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Azambuja</LastName><ForeName>Evandro</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Maturitas</MedlineTA><NlmUniqueID>7807333</NlmUniqueID><ISSNLinking>0378-5122</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019584" MajorTopicYN="N">Hot Flashes</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007247" MajorTopicYN="N">Infertility, Female</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="N">Sleep Initiation and Maintenance Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>09</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>09</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22014722</ArticleId><ArticleId IdType="pii">S0378-5122(11)00329-X</ArticleId><ArticleId IdType="doi">10.1016/j.maturitas.2011.09.008</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Portugal</li></country></list><tree><noCountry><name sortKey="De Azambuja, Evandro" sort="De Azambuja, Evandro" uniqKey="De Azambuja E" first="Evandro" last="De Azambuja">Evandro De Azambuja</name></noCountry><country name="Portugal"><noRegion><name sortKey="Pinto, Ana Catarina" sort="Pinto, Ana Catarina" uniqKey="Pinto A" first="Ana Catarina" last="Pinto">Ana Catarina Pinto</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004753 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004753 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:22014722
|texte= Improving quality of life after breast cancer: dealing with symptoms.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:22014722" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |